Difference between revisions of "Part:BBa K5237007"

Line 1: Line 1:
 
 
__NOTOC__
 
__NOTOC__
 
<partinfo>BBa_K5237007</partinfo>
 
<partinfo>BBa_K5237007</partinfo>
Line 25: Line 24:
 
     border: 0.5px solid black;
 
     border: 0.5px solid black;
 
     border-collapse: collapse;
 
     border-collapse: collapse;
 +
    padding: 5px;
 
   }
 
   }
  
   th,
+
   .thumbcaption {
   td {
+
    text-align: justify !important;
     padding: 1.5px;
+
  }
 +
 
 +
 
 +
  a[href ^="https://"],
 +
   .link-https {
 +
    background: none !important;
 +
     padding-right: 0px !important;
 
   }
 
   }
 
</style>
 
</style>
Line 37: Line 43:
 
   <section id="1">
 
   <section id="1">
 
     <h1>Staple subunit: GCN4</h1>
 
     <h1>Staple subunit: GCN4</h1>
     <p>GCN4 is a yeast transcription factor belonging to the bZip family of DNA-binding proteins.  
+
     <p>GCN4 is a yeast transcription factor belonging to the bZip family of DNA-binding proteins.
       We use GCN4 to study DNA-binding kinetics in our "Mini staples" that bring two DNA target sites into proximity by binding them simultaneously.  
+
       We use GCN4 to study DNA-binding kinetics in our "Mini staples" that bring two DNA target sites into proximity by
      </p>
+
      binding them simultaneously.
     <p>&nbsp;</p>
+
    </p>
 +
     <p> </p>
 
   </section>
 
   </section>
   <div id="toc" class="toc">
+
   <div class="toc" id="toc">
 
     <div id="toctitle">
 
     <div id="toctitle">
 
       <h1>Contents</h1>
 
       <h1>Contents</h1>
Line 58: Line 65:
 
       <li class="toclevel-1 tocsection-5"><a href="#4"><span class="tocnumber">4</span> <span
 
       <li class="toclevel-1 tocsection-5"><a href="#4"><span class="tocnumber">4</span> <span
 
             class="toctext">Results</span></a>
 
             class="toctext">Results</span></a>
            <ul>
+
        <ul>
              <li class="toclevel-2 tocsection-6"><a href="#4.1"><span class="tocnumber">4.1</span class="toctext">Protein expression and purification</span></a>
+
          <li class="toclevel-2 tocsection-6"><a href="#4.1"><span class="tocnumber">4.1</span> <span class="toctext">Protein expression and
              </li>
+
              purification</span></a>
              <li class="toclevel-2 tocsection-7"><a href="#4.2"><span class="tocnumber">4.2</span class="toctext">Electrophoretic Mobility shift assay</span></a></li>
+
          </li>
            </ul>
+
          <li class="toclevel-2 tocsection-7"><a href="#4.2"><span class="tocnumber">4.2</span> <span class="toctext">Electrophoretic Mobility
 
+
              shift assay</span></a>
 +
          </li>
 +
          <li class="toclevel-2 tocsection-8"><a href="#4.3"><span class="tocnumber">4.3</span> <span class="toctext"><i>In Silico</i>
 +
              Characterization using DaVinci</span></a>
 +
        </ul>
 
       </li>
 
       </li>
 
       <li class="toclevel-1 tocsection-8"><a href="#5"><span class="tocnumber">5</span> <span
 
       <li class="toclevel-1 tocsection-8"><a href="#5"><span class="tocnumber">5</span> <span
Line 71: Line 82:
 
   </div>
 
   </div>
 
   <section>
 
   <section>
 +
    <p><br /><br /></p>
 
     <font size="5"><b>The PICasSO Toolbox </b> </font>
 
     <font size="5"><b>The PICasSO Toolbox </b> </font>
    <p><br></p>
+
     <div class="thumb" style="margin-top:10px;"></div>
     <div class="thumb"></div>
+
    <div class="thumbinner" style="width:550px"><img alt="" class="thumbimage"
      <div class="thumbinner" style="width:550px"><img alt="" src="https://static.igem.wiki/teams/5237/wetlab-results/registry-part-collection-engineering-cycle-example-overview.svg" style="width:99%;" class="thumbimage">
+
        src="https://static.igem.wiki/teams/5237/wetlab-results/registry-part-collection-engineering-cycle-example-overview.svg"
        <div class="thumbcaption">
+
        style="width:99%;" />
          <i><b>Figure 1: Example how the part collection can be used to engineer new staples</b></i>
+
      <div class="thumbcaption">
        </div>
+
        <i><b>Figure 1: How our part collection can be used to engineer new staples</b></i>
 
       </div>
 
       </div>
 
     </div>
 
     </div>
   
 
  
 
     <p>
 
     <p>
       <br>
+
       <br />
       The 3D organization of the genome plays a crucial role in regulating gene expression in eukaryotic cells,
+
       Next to the well-studied linear DNA sequence, the 3D spatial organization of DNA plays a crucial role in gene
       impacting cellular behavior, evolution, and disease. Beyond the linear DNA sequence, the spatial arrangement of
+
       regulation,
       chromatin, influenced by DNA-DNA interactions, shapes pathways of gene regulation. However, the tools to precisely
+
       cell fate, disease development and more. However, the tools to precisely manipulate this genomic architecture
      manipulate this genomic architecture remain limited, rendering it challenging to explore the full potential of the
+
      remain limited, rendering it challenging to explore the full potential of the
 
       3D genome in synthetic biology. We - iGEM Team Heidelberg 2024 - have developed PICasSO, a powerful molecular
 
       3D genome in synthetic biology. We - iGEM Team Heidelberg 2024 - have developed PICasSO, a powerful molecular
 
       toolbox based on various DNA-binding proteins to address this issue.
 
       toolbox based on various DNA-binding proteins to address this issue.
 
 
     </p>
 
     </p>
 
     <p>
 
     <p>
Line 99: Line 109:
 
       Beyond its versatility, PICasSO includes robust assay systems to support the engineering, optimization, and
 
       Beyond its versatility, PICasSO includes robust assay systems to support the engineering, optimization, and
 
       testing of new staples, ensuring functionality <i>in vitro</i> and <i>in vivo</i>. We took special care to include
 
       testing of new staples, ensuring functionality <i>in vitro</i> and <i>in vivo</i>. We took special care to include
       parts crucial for testing every step of the cycle (design, build, test, learn) when engineering new parts
+
       parts crucial for testing every step of the cycle (design, build, test, learn) when engineering new parts.
 
     </p>
 
     </p>
 
+
     <p>At its heart, the PICasSO part collection consists of three categories. <br /><b>(i)</b> Our <b>DNA-binding
     <p>At its heart, the PICasSO part collection consists of three categories. <br><b>(i)</b> Our <b>DNA-binding proteins</b>
+
        proteins</b>
 
       include our
 
       include our
 
       finalized enhancer hijacking Cas staple as well as half staples that can be used by scientists to compose entirely
 
       finalized enhancer hijacking Cas staple as well as half staples that can be used by scientists to compose entirely
       new Cas staples in the future. We also include our simple staples that serve as controls for successful stapling
+
       new Cas staples in the future. We also include our Simple staples that serve as controls for successful stapling
       and can be further engineered to create alternative, simpler and more compact staples. <br>
+
       and can be further engineered to create alternative, simpler and more compact staples. <br />
       <b>(ii)</b> As <b>functional elements</b>, we list additional parts that enhance the functionality of our Cas and Basic staples. These
+
       <b>(ii)</b> As <b>functional elements</b>, we list additional parts that enhance the functionality of our Cas and
 +
      Basic staples. These
 
       consist of
 
       consist of
 
       protease-cleavable peptide linkers and inteins that allow condition-specific, dynamic stapling <i>in vivo</i>.
 
       protease-cleavable peptide linkers and inteins that allow condition-specific, dynamic stapling <i>in vivo</i>.
       Besides staple functionality, we also include the parts to enable the efficient delivery of PICasSO's constructs with our
+
       Besides staple functionality, we also include the parts to enable the efficient delivery of PICasSO's constructs
       interkingdom conjugation system. <br>
+
      with our
       <b>(iii)</b> As the final component of our collection, we provide parts that support the use of our <b>custom readout
+
       interkingdom conjugation system. <br />
 +
       <b>(iii)</b> As the final category of our collection, we provide parts that support the use of our <b>custom
 +
        readout
 
         systems</b>. These include components of our established FRET-based proximity assay system, enabling users to
 
         systems</b>. These include components of our established FRET-based proximity assay system, enabling users to
 
       confirm
 
       confirm
 
       accurate stapling. Additionally, we offer a complementary, application-oriented testing system for functional
 
       accurate stapling. Additionally, we offer a complementary, application-oriented testing system for functional
       readout via a luciferase reporter, which allows for straightforward experimental simulation of enhancer hijacking.
+
       readouts via a luciferase reporter, which allows for straightforward experimental simulation of enhancer hijacking
 +
      in mammalian cells.
 
     </p>
 
     </p>
 
     <p>
 
     <p>
       The following table gives a complete overview of all parts in our PICasSO toolbox. The highlighted parts showed
+
       The following table gives a comprehensive overview of all parts in our PICasSO toolbox. <mark
      exceptional performance as described on our iGEM wiki and can serve as a reference. The other parts in the
+
        style="background-color: #FFD700; color: black;">The highlighted parts showed
 +
        exceptional performance as described on our iGEM wiki and can serve as a reference.</mark> The other parts in
 +
      the
 
       collection are versatile building blocks designed to provide future iGEMers with the flexibility to engineer their
 
       collection are versatile building blocks designed to provide future iGEMers with the flexibility to engineer their
       own custom Cas staples, enabling further optimization and innovation.<br>
+
       own custom Cas staples, enabling further optimization and innovation.<br />
 
     </p>
 
     </p>
 
     <p>
 
     <p>
       <font size="4"><b>Our part collection includes:</b></font><br>
+
       <font size="4"><b>Our part collection includes:</b></font><br />
 
     </p>
 
     </p>
 
+
     <table style="width: 90%; padding-right:10px;">
     <table style="width: 90%;">
+
       <td align="left" colspan="3"><b>DNA-binding proteins: </b>
       <td colspan="3" align="left"><b>DNA-binding proteins: </b>
+
 
         The building blocks for engineering of custom staples for DNA-DNA interactions with a modular system ensuring
 
         The building blocks for engineering of custom staples for DNA-DNA interactions with a modular system ensuring
 
         easy assembly.</td>
 
         easy assembly.</td>
Line 135: Line 150:
 
         <tr bgcolor="#FFD700">
 
         <tr bgcolor="#FFD700">
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237000" target="_blank">BBa_K5237000</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237000" target="_blank">BBa_K5237000</a></td>
           <td>fgRNA Entryvector MbCas12a-SpCas9</td>
+
           <td>fgRNA Entry vector MbCas12a-SpCas9</td>
 
           <td>Entryvector for simple fgRNA cloning via SapI</td>
 
           <td>Entryvector for simple fgRNA cloning via SapI</td>
 
         </tr>
 
         </tr>
         <tr>
+
         <tr bgcolor="#FFD700">
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237001" target="_blank">BBa_K5237001</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237001" target="_blank">BBa_K5237001</a></td>
 
           <td>Staple subunit: dMbCas12a-Nucleoplasmin NLS</td>
 
           <td>Staple subunit: dMbCas12a-Nucleoplasmin NLS</td>
           <td>Staple subunit that can be combined to form a functional staple, for example with fgRNA and dCas9 </td>
+
           <td>Staple subunit that can be combined with sgRNA or fgRNA and dCas9 to form a functional staple</td>
 
         </tr>
 
         </tr>
         <tr>
+
         <tr bgcolor="#FFD700">
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237002" target="_blank">BBa_K5237002</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237002" target="_blank">BBa_K5237002</a></td>
 
           <td>Staple subunit: SV40 NLS-dSpCas9-SV40 NLS</td>
 
           <td>Staple subunit: SV40 NLS-dSpCas9-SV40 NLS</td>
           <td>Staple subunit that can be combined to form a functional staple, for example with our fgRNA or dCas12a
+
           <td>Staple subunit that can be combined witha sgRNA or fgRNA and dCas12avto form a functional staple
 
           </td>
 
           </td>
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237003" target="_blank">BBa_K5237003</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237003" target="_blank">BBa_K5237003</a></td>
           <td>Cas-Staple: SV40 NLS-dMbCas12a-dSpCas9-Nucleoplasmin NLS</td>
+
           <td>Cas Staple: SV40 NLS-dMbCas12a-dSpCas9-Nucleoplasmin NLS</td>
           <td>Functional Cas staple that can be combined with sgRNA or fgRNA to bring two DNA strands in close proximity
+
           <td>Functional Cas staple that can be combined with sgRNA or fgRNA to bring two DNA strands into close
 +
            proximity
 
           </td>
 
           </td>
 
         </tr>
 
         </tr>
Line 158: Line 174:
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237004" target="_blank">BBa_K5237004</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237004" target="_blank">BBa_K5237004</a></td>
 
           <td>Staple subunit: Oct1-DBD</td>
 
           <td>Staple subunit: Oct1-DBD</td>
           <td>Staple subunit that can be combined to form a functional staple, for example with TetR.<br>
+
           <td>Staple subunit that can be combined to form a functional staple, for example with TetR.<br />
 
             Can also be combined with a fluorescent protein as part of the FRET proximity assay</td>
 
             Can also be combined with a fluorescent protein as part of the FRET proximity assay</td>
 
         </tr>
 
         </tr>
Line 164: Line 180:
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237005" target="_blank">BBa_K5237005</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237005" target="_blank">BBa_K5237005</a></td>
 
           <td>Staple subunit: TetR</td>
 
           <td>Staple subunit: TetR</td>
           <td>Staple subunit that can be combined to form a functional staple, for example with Oct1.<br>
+
           <td>Staple subunit that can be combined to form a functional staple, for example with Oct1.<br />
 
             Can also be combined with a fluorescent protein as part of the FRET proximity assay</td>
 
             Can also be combined with a fluorescent protein as part of the FRET proximity assay</td>
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237006" target="_blank">BBa_K5237006</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237006" target="_blank">BBa_K5237006</a></td>
           <td>Simple taple: TetR-Oct1</td>
+
           <td>Simple staple: TetR-Oct1</td>
 
           <td>Functional staple that can be used to bring two DNA strands in close proximity</td>
 
           <td>Functional staple that can be used to bring two DNA strands in close proximity</td>
 
         </tr>
 
         </tr>
Line 189: Line 205:
 
         </tr>
 
         </tr>
 
       </tbody>
 
       </tbody>
       <td colspan="3" align="left"><b>Functional elements: </b>
+
       <td align="left" colspan="3"><b>Functional elements: </b>
         Protease cleavable peptide linkers and inteins are used to control and modify staples for further optimization
+
         Protease-cleavable peptide linkers and inteins are used to control and modify staples for further optimization
         for custom applications.</td>
+
         for custom applications</td>
 
       <tbody>
 
       <tbody>
 
         <tr bgcolor="#FFD700">
 
         <tr bgcolor="#FFD700">
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237010" target="_blank">BBa_K5237010</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237010" target="_blank">BBa_K5237010</a></td>
           <td>Cathepsin B-Cleavable Linker (GFLG)</td>
+
           <td>Cathepsin B-cleavable Linker: GFLG</td>
           <td>Cathepsin B cleavable peptide linker, that can be used to combine two staple subunits ,to make responsive
+
           <td>Cathepsin B-cleavable peptide linker that can be used to combine two staple subunits to make responsive
 
             staples</td>
 
             staples</td>
 
         </tr>
 
         </tr>
Line 202: Line 218:
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237011" target="_blank">BBa_K5237011</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237011" target="_blank">BBa_K5237011</a></td>
 
           <td>Cathepsin B Expression Cassette</td>
 
           <td>Cathepsin B Expression Cassette</td>
           <td>Cathepsin B which can be selectively express to cut the cleavable linker</td>
+
           <td>Expression Cassette for the overexpression of cathepsin B</td>
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237012" target="_blank">BBa_K5237012</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237012" target="_blank">BBa_K5237012</a></td>
 
           <td>Caged NpuN Intein</td>
 
           <td>Caged NpuN Intein</td>
           <td>Undergoes protein transsplicing after protease activation, can be used to create functionalized staple
+
           <td>A caged NpuN split intein fragment that undergoes protein <i>trans</i>-splicing after protease activation.
 +
            Can be used to create functionalized staples
 
             units</td>
 
             units</td>
 
         </tr>
 
         </tr>
Line 213: Line 230:
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237013" target="_blank">BBa_K5237013</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237013" target="_blank">BBa_K5237013</a></td>
 
           <td>Caged NpuC Intein</td>
 
           <td>Caged NpuC Intein</td>
           <td>Undergoes protein transsplicing after protease activation, can be used to create functionalized staple
+
           <td>A caged NpuC split intein fragment that undergoes protein <i>trans</i>-splicing after protease activation.
 +
            Can be used to create functionalized staples
 
             units</td>
 
             units</td>
 
         </tr>
 
         </tr>
Line 219: Line 237:
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237014" target="_blank">BBa_K5237014</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237014" target="_blank">BBa_K5237014</a></td>
 
           <td>fgRNA processing casette</td>
 
           <td>fgRNA processing casette</td>
           <td>Processing casette to produce multiple fgRNAs from one transcript, can be used for multiplexing</td>
+
           <td>Processing casette to produce multiple fgRNAs from one transcript, that can be used for multiplexed 3D
 +
            genome reprograming</td>
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
Line 226: Line 245:
 
           <td>Interkindom conjugation between bacteria and mammalian cells, as alternative delivery tool for large
 
           <td>Interkindom conjugation between bacteria and mammalian cells, as alternative delivery tool for large
 
             constructs</td>
 
             constructs</td>
 +
        </tr>
 +
        <tr>
 +
          <td><a href="https://parts.igem.org/Part:BBa_K4643003" target="_blank">BBa_K4643003</a></td>
 +
          <td>incP origin of transfer</td>
 +
          <td>Origin of transfer that can be cloned into the plasmid vector and used for conjugation as a means of
 +
            delivery</td>
 
         </tr>
 
         </tr>
 
       </tbody>
 
       </tbody>
       <td colspan="3" align="left"><b>Readout Systems: </b>
+
       <td align="left" colspan="3"><b>Readout Systems: </b>
 
         FRET and enhancer recruitment to measure proximity of stapled DNA in bacterial and mammalian living cells
 
         FRET and enhancer recruitment to measure proximity of stapled DNA in bacterial and mammalian living cells
         enabling swift testing and easy development for new systems.</td>
+
         enabling swift testing and easy development for new systems</td>
 
       <tbody>
 
       <tbody>
 
         <tr bgcolor="#FFD700">
 
         <tr bgcolor="#FFD700">
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237016" target="_blank">BBa_K5237016</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237016" target="_blank">BBa_K5237016</a></td>
 
           <td>FRET-Donor: mNeonGreen-Oct1</td>
 
           <td>FRET-Donor: mNeonGreen-Oct1</td>
           <td>Donor part for the FRET assay binding the Oct1 binding cassette. Can be used to visualize DNA-DNA
+
           <td>FRET Donor-Fluorpohore fused to Oct1-DBD that binds to the Oct1 binding cassette. Can be used to visualize
 +
            DNA-DNA
 
             proximity</td>
 
             proximity</td>
 
         </tr>
 
         </tr>
Line 247: Line 273:
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237018" target="_blank">BBa_K5237018</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237018" target="_blank">BBa_K5237018</a></td>
 
           <td>Oct1 Binding Casette</td>
 
           <td>Oct1 Binding Casette</td>
           <td>DNA sequence containing 12 Oct1 binding motifs, can be used for different assays such as the FRET
+
           <td>DNA sequence containing 12 Oct1 binding motifs, compatible with various assays such as the FRET
 
             proximity assay</td>
 
             proximity assay</td>
 
         </tr>
 
         </tr>
Line 258: Line 284:
 
         <td><a href="https://parts.igem.org/Part:BBa_K5237020" target="_blank">BBa_K5237020</a></td>
 
         <td><a href="https://parts.igem.org/Part:BBa_K5237020" target="_blank">BBa_K5237020</a></td>
 
         <td>Cathepsin B-Cleavable Trans-Activator: NLS-Gal4-GFLG-VP64</td>
 
         <td>Cathepsin B-Cleavable Trans-Activator: NLS-Gal4-GFLG-VP64</td>
         <td>Readout system that responds to protease activity. It was used to test Cathepsin-B cleavable linker.</td>
+
         <td>Readout system that responds to protease activity. It was used to test cathepsin B-cleavable linker</td>
        </tr>
+
 
 
         <tr>
 
         <tr>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237021" target="_blank">BBa_K5237021</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237021" target="_blank">BBa_K5237021</a></td>
 
           <td>NLS-Gal4-VP64</td>
 
           <td>NLS-Gal4-VP64</td>
           <td>Trans-activating enhancer, that can be used to simulate enhancer hijacking. </td>
+
           <td>Trans-activating enhancer, that can be used to simulate enhancer hijacking</td>
 
         </tr>
 
         </tr>
 
         <td><a href="https://parts.igem.org/Part:BBa_K5237022" target="_blank">BBa_K5237022</a></td>
 
         <td><a href="https://parts.igem.org/Part:BBa_K5237022" target="_blank">BBa_K5237022</a></td>
 
         <td>mCherry Expression Cassette: UAS, minimal Promotor, mCherry</td>
 
         <td>mCherry Expression Cassette: UAS, minimal Promotor, mCherry</td>
         <td>Readout system for enhancer binding. It was used to test Cathepsin-B cleavable linker.</td>
+
         <td>Readout system for enhancer binding. It was used to test cathepsin B-cleavable linker</td>
        </tr>
+
 
 
         <tr>
 
         <tr>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237023" target="_blank">BBa_K5237023</a></td>
 
           <td><a href="https://parts.igem.org/Part:BBa_K5237023" target="_blank">BBa_K5237023</a></td>
 
           <td>Oct1 - 5x UAS binding casette</td>
 
           <td>Oct1 - 5x UAS binding casette</td>
           <td>Oct1 and UAS binding cassette, that was used for the simulated enhancer hijacking assay.</td>
+
           <td>Oct1 and UAS binding cassette, that was used for the simulated enhancer hijacking assay</td>
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
Line 278: Line 304:
 
           <td>TRE-minimal promoter- firefly luciferase</td>
 
           <td>TRE-minimal promoter- firefly luciferase</td>
 
           <td>Contains Firefly luciferase controlled by a minimal promoter. It was used as a luminescence readout for
 
           <td>Contains Firefly luciferase controlled by a minimal promoter. It was used as a luminescence readout for
             simulated enhancer hijacking.</td>
+
             simulated enhancer hijacking</td>
 
         </tr>
 
         </tr>
 
       </tbody>
 
       </tbody>
 
     </table>
 
     </table>
    </p>
 
 
   </section>
 
   </section>
 
   <section id="1">
 
   <section id="1">
Line 288: Line 313:
 
   </section>
 
   </section>
 
</body>
 
</body>
</html>
 
  
 +
</html>
 
<!--################################-->
 
<!--################################-->
<span class='h3bb'>Sequence and Features</span>
+
<span class="h3bb">Sequence and Features</span>
 
<partinfo>BBa_K5237007 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K5237007 SequenceAndFeatures</partinfo>
 
<!--################################-->
 
<!--################################-->
 
 
<html>
 
<html>
 
 
 
<section id="2">
 
<section id="2">
    <h1>2. Usage and Biology</h1>
+
  <h1>2. Usage and Biology</h1>
    <p>
+
  <p>
      GCN4 is a yeast transcription factor from the bZip family of DNA-binding proteins, first discovered by McKnight and co-workers in 1988.  
+
    GCN4 is a yeast transcription factor from the bZip family of DNA-binding proteins, first discovered by McKnight and
      The bZip motif features a coiled-coil leucine zipper dimerization domain paired with a highly charged basic region, which directly interacts  
+
    co-workers in 1988.
      with DNA. GCN4 binds specifically to the cyclic AMP response element (CRE) DNA sequence (5' ATGACGTCAT 3') in the promoter regions of target genes, primarily through its basic  
+
    The bZip motif features a coiled-coil leucine zipper dimerization domain paired with a highly charged basic region,
      residues at the N-terminus.
+
    which directly interacts
 +
    with DNA. GCN4 binds specifically to the cyclic AMP response element (CRE) DNA sequence (5' ATGACGTCAT 3') in the
 +
    promoter regions of target genes, primarily through its basic
 +
    residues at the N-terminus.
 +
  </p>
 +
  <p>
 +
    In our project, GCN4 was employed to study DNA-binding kinetics and develop a minimal "Mini staple" that brings two
 +
    DNA target sites into proximity
 +
    by binding them simultaneously. This "Mini staple" was designed as a versatile tool for precise DNA manipulation in
 +
    synthetic biology applications.
 +
  </p>
 +
  <p>
 +
    The DNA-binding properties of GCN4 were tested using an electrophoretic mobility shift assay (EMSA) to quantify
 +
    binding affinity and kinetics.
 +
    EMSA is a widely adopted method to study DNA-protein interactions. It works on the principle that nucleic acids
 +
    bound to proteins exhibit reduced
 +
    electrophoretic mobility compared to unbound nucleic acids (Hellman &amp; Fried, 2007). EMSA can be employed both
 +
    qualitatively, to assess DNA-binding
 +
    capabilities, and quantitatively, to determine critical parameters such as binding stoichiometry and the apparent
 +
    dissociation constant (K<sub>d</sub>)
 +
    (Fried, 1989).
 +
  </p>
 +
</section>
 +
<section id="3">
 +
  <h1>3. Assembly and part evolution</h1>
 +
  <p>
 +
    The GCN4 amino acid sequence was taken from literature (Hollenbeck et al. 2001) and codon optimized for <i>E.
 +
      coli</i>.
 +
    A FLAG-tag (DYKDDDDK) was added to the N-terminus for protein purification. The FLAG-tag can be cleaved off using an
 +
    Enterokinase, if necessary.
 +
    The FLAG-GCN4 sequence was cloned into a T7 expression vector and expressed using <i>E. coli</i> BL21 (DE3) cells.
 +
  </p>
 +
</section>
 +
<section id="4">
 +
  <h1>4. Results</h1>
 +
  <section id="4.1">
 +
    <h2>4.1 Protein expression and purification</h2>
 +
    <p>The FLAG-GCN4 protein could be readily expressed in <i>E. coli</i> BL21 (DE3). The protein was purified using an
 +
      anti-FLAG resin.
 +
      Fractions taken during purification were analyzed by SDS-PAGE. Purified protein was quantified using a Lowry
 +
      assay, 1.18 mg/mL were obtained, resulting in 153 µM of monomeric FLAG-GCN4.
 
     </p>
 
     </p>
     <p>
+
     <div class="thumb">
      In our project, GCN4 was employed to study DNA-binding kinetics and develop a minimal "Mini staple" that brings two DNA target sites into proximity
+
      <div class="thumbinner" style="width:500px">
      by binding them simultaneously. This "Mini staple" was designed as a versatile tool for precise DNA manipulation in synthetic biology applications.
+
        <img alt="" class="thumbimage"
    </p>
+
          src="https://static.igem.wiki/teams/5237/wetlab-results/mist-sds-page-expression-validation.svg"
    <p>
+
          style="width:99%;" />
      The DNA-binding properties of GCN4 were tested using an electrophoretic mobility shift assay (EMSA) to quantify binding affinity and kinetics.
+
        <div class="thumbcaption">
      EMSA is a widely adopted method to study DNA-protein interactions. It works on the principle that nucleic acids bound to proteins exhibit reduced
+
          <i><b>Figure 2: SDS-PAGE analysis of FLAG-GCN4 purification</b> Fractions analysed are the raw lysate, flow
      electrophoretic mobility compared to unbound nucleic acids (Hellman & Fried, 2007). EMSA can be employed both qualitatively, to assess DNA-binding
+
            through and eluate.
      capabilities, and quantitatively, to determine critical parameters such as binding stoichiometry and the apparent dissociation constant (K<sub>d</sub>)
+
      (Fried, 1989).
+
    </p>
+
  </section>
+
  <section id="3">
+
    <h1>3. Assembly and part evolution</h1>
+
    <p>
+
      The GCN4 amino acid sequence was taken from literature (Hollenbeck et al. 2001) and codon optimized for <i>E. coli</i>.
+
      A FLAG-tag (DYKDDDDK) was added to the N-terminus for protein purification. The FLAG-tag can be cleaved off using an Enterokinase, if necessary.
+
      The FLAG-GCN4 sequence was cloned into a T7 expression vector and expressed using <i>E. coli</i> BL21 (DE3) cells.
+
    </p>
+
  </section>
+
  <section id="4">
+
    <h1>4. Results</h1>
+
    <section id="4.1">
+
      <h2>4.1 Protein expression and purification</h2>
+
      <p>The FLAG-GCN4 protein could be readily expressed in <i>E. coli</i> BL21 (DE3). The protein was purified using an anti-FLAG resin.
+
        Fractions taken during purification were analyzed by SDS-PAGE. Purified protein was quantified using a Lowry assay, 1.18 mg/mL were obtained, resulting in 153 µM of monomeric FLAG-GCN4.
+
      </p>
+
      <div class="thumb">
+
        <div class="thumbinner" style="width:500px">
+
          <img alt="" src="https://static.igem.wiki/teams/5237/wetlab-results/mist-sds-page-expression-validation.svg" style="width:99%;" class="thumbimage">
+
          <div class="thumbcaption">
+
            <i><b>Figure 2: SDS-PAGE analysis of FLAG-GCN4 purification</b> Fractions analysed are the raw lysate, flow through and eluate.
+
 
             Depicted is GCN4 (this part), rGCN4 (<a href="https://parts.igem.org/Part:BBa_K5237008"
 
             Depicted is GCN4 (this part), rGCN4 (<a href="https://parts.igem.org/Part:BBa_K5237008"
 
               target="_blank">BBa_K5237008</a>), and bGCN4 (<a href="https://parts.igem.org/Part:BBa_K5237009"
 
               target="_blank">BBa_K5237008</a>), and bGCN4 (<a href="https://parts.igem.org/Part:BBa_K5237009"
               target="_blank">BBa_K5237009</a>)</i>. Protein size is indicated next to construct name and purified band with protein of interest highlighted by a red box.
+
               target="_blank">BBa_K5237009</a>). Protein size is indicated next to construct name and purified band
              </i>
+
            with protein of interest highlighted by a red box.</i>
          </div>
+
 
         </div>
 
         </div>
 
       </div>
 
       </div>
     </section>
+
     </div>
    <section id="4.2">
+
  </section>
      <h2>4.2 Electrophoretic Mobility shift assay</h2>
+
  <section id="4.2">
      <p>
+
    <h2>4.2 Electrophoretic Mobility shift assay</h2>
        The Electrophoretic mobility shift assay (EMSA) is a widely adopted method used to study DNA-protein
+
 
        interactions. EMSa functions on the basis that nucleic acids bound to proteins have reduced electrophoretic
+
    <div class="thumb tright">
        mobility, compared to their counterpart. (Hellman & Fried, 2007). Mobility-shift
+
      <div class="thumbinner" style="width:310px;">
        assays can both be used to qualitatively assess DNA binding capabilities or quantitatively to determine binding
+
        <img alt="" class="thumbimage"
        stoichiometry and kinetics such as the apparent dissociation constant (K<sub>d</sub>) (Fried, 1989).
+
          src="https://static.igem.wiki/teams/5237/figures-corrected/leucin-zipper-emsa.svg" style="width:99%;" />
      </p>
+
        <div class="thumbcaption">
      <div class="thumb">
+
          <i>
        <div class="thumbinner" style="width:40%;">
+
            <b>Figure 3: Overview Image of Electrophoretic Mobility Shift Assay (EMSA)</b>
          <img alt="" src="https://static.igem.wiki/teams/5237/figures-corrected/leucin-zipper-emsa.svg"
+
          </i>
          style="width:99%;" class="thumbimage">
+
          <div class="thumbcaption">
+
            <i>
+
              <b>Figure 3: Overview Image of Electrophoretic Mobility Shift Assay (EMSA)</b>
+
            </i>
+
          </div>
+
 
         </div>
 
         </div>
 
       </div>
 
       </div>
      <p>
+
    </div>
        GCN4 was tested for its DNA-binding capabilities using an electrophoretic mobility shift assay (EMSA). The protein was incubated with a DNA probe containing the GCN4 binding site. The formation of a protein-DNA complex was analyzed by native PAGE.
+
    <p align="justify"></p>
        To further analyze DNA binding, quantitative shift assays were performed for GCN4 and rGCN4 (<a href="https://parts.igem.org/Part:BBa:K5237008">BBa_K5237008</a>).
+
    The Electrophoretic mobility shift assay (EMSA) is a widely adopted method used to study DNA-protein
        0.5 µM DNA were incubated with varying concentrations of protein until equilibration. After
+
    interactions. EMSA functions on the basis that nucleic acids bound to proteins have reduced electrophoretic
        electrophoresis, bands were stained with SYBR-Safe and quantified based on pixel intensity. The
+
    mobility, compared to their counterpart. (Hellman &amp; Fried, 2007). Mobility-shift
        obtained values were fitted to equation 1, describing formation of a 2:1 protein-DNA complex:
+
    assays can both be used to qualitatively assess DNA binding capabilities or quantitatively to determine binding
        <br><br>
+
    stoichiometry and kinetics such as the apparent dissociation constant (K<sub>d</sub>) (Fried, 1989).
        Θ<sub>app</sub> = Θ<sub>min</sub> + (Θ<sub>max</sub> - Θ<sub>min</sub>) &#215;
+
    </p>
        (K<sub>a</sub><sup>2</sup> [L]<sub>tot</sub><sup>2</sup>) / (1 + K<sub>a</sub><sup>2</sup>
+
    <p>
        [L]<sub>tot</sub><sup>2</sup>)
+
      GCN4 was tested for its DNA-binding capabilities using an electrophoretic mobility shift assay (EMSA). The protein
        <span style="float: right;">Equation 1</span>
+
      was incubated with a DNA probe containing the GCN4 binding site. The formation of a protein-DNA complex was
        <br><br>
+
      analyzed by native PAGE.
        Here [L]<sub>tot</sub> describes the total protein monomer concentration, K<sub>a</sub>
+
      To further analyze DNA binding, quantitative shift assays were performed for GCN4 and rGCN4 (<a
        corresponds
+
        href="https://parts.igem.org/Part:BBa:K5237008">BBa_K5237008</a>).
        to the apparent monomeric equilibration constant. The Θ<sub>min/max</sub> values are the
+
      0.5 µM DNA were incubated with varying concentrations of protein until equilibration. After
        experimentally
+
      electrophoresis, bands were stained with SYBR-Safe and quantified based on pixel intensity. The
        determined site saturation values (For this experiment 0 and 1 were chosen for min and max
+
      obtained values were fitted to equation 1, describing formation of a 2:1 protein-DNA complex:
        respectively). GCN4 binds to its optimal DNA binding motif with an apparent dissociation
+
      <br /><br />
        constant K<sub>k</sub> of (0.2930.033)&#215;10<sup>-6</sup> M, which is almost identical to the
+
      Θ<sub>app</sub> = Θ<sub>min</sub> + (Θ<sub>max</sub> - Θ<sub>min</sub>) ×
        rGCN4 binding
+
      (K<sub>a</sub><sup>2</sup> [L]<sub>tot</sub><sup>2</sup>) / (1 + K<sub>a</sub><sup>2</sup>
        affinity to INVii a <sub>d</sub> of (0.2980.030)&#215;10<sup>-6</sup> M.
+
      [L]<sub>tot</sub><sup>2</sup>)
      </p>
+
      <span style="float: right;">Equation 1</span>
      <div class="thumb">
+
      <br /><br />
        <div class="thumbinner" style="width:500px">
+
      Here [L]<sub>tot</sub> describes the total protein monomer concentration, K<sub>a</sub>
          <img alt="" src="https://static.igem.wiki/teams/5237/wetlab-results/mist-leucine-zipper-kd-plot.svg" style="width:99%;" class="thumbimage">
+
      corresponds
          <div class="thumbcaption">
+
      to the apparent monomeric equilibration constant. The Θ<sub>min/max</sub> values are the
            <i><b>Figure 4: Quantitative EMSA</b>Quantitative assessment of binding affinity for GCN4 and rGCN4. Proteins of
+
      experimentally
              different concentrations were incubated with 0.5 µM DNA until equilibrium and fraction bound analyzed, after gel electrophoresis, by dividing pixel intensity of
+
      determined site saturation values (For this experiment 0 and 1 were chosen for min and max
              bound fraction with pixel intensity of bound and unbound fraction. At least three separate measurements were conducted
+
      respectively). GCN4 binds to its optimal DNA binding motif with an apparent dissociation
              for each data point. Values are presented as mean +/- SD.</i>
+
      constant K<sub>k</sub> of (0.2930.033)×10<sup>-6</sup> M, which is almost identical to the
          </div>
+
      rGCN4 binding
 +
      affinity to INVii a <sub>d</sub> of (0.2980.030)×10<sup>-6</sup> M.
 +
    </p>
 +
    <div class="thumb">
 +
      <div class="thumbinner" style="width:500px">
 +
        <img alt="" class="thumbimage"
 +
          src="https://static.igem.wiki/teams/5237/wetlab-results/mist-leucine-zipper-kd-plot.svg" style="width:99%;" />
 +
        <div class="thumbcaption">
 +
          <i><b>Figure 4: Quantitative EMSA</b>Quantitative assessment of binding affinity for GCN4 and rGCN4. Proteins
 +
            of
 +
            different concentrations were incubated with 0.5 µM DNA until equilibrium and fraction bound analyzed, after
 +
            gel electrophoresis, by dividing pixel intensity of
 +
            bound fraction with pixel intensity of bound and unbound fraction. At least three separate measurements were
 +
            conducted
 +
            for each data point. Values are presented as mean +/- SD.</i>
 +
        </div>
 
       </div>
 
       </div>
 
       <p>
 
       <p>
         The apparent binding kinetics calculated for GCN4 ((0.2930.033) &#215; 10<sup>-6</sup> M) and rGCN4
+
         The apparent binding kinetics calculated for GCN4 ((0.2930.033) × 10<sup>-6</sup> M) and rGCN4
         ((0.2980.030) &#215; 10<sup>-6</sup> M) are
+
         ((0.2980.030) × 10<sup>-6</sup> M) are
         approximately a factor 10 higher then those described in literature ((96) &#215; 10<sup>-8</sup> M for
+
         approximately a factor 10 higher then those described in literature ((96) × 10<sup>-8</sup> M for
         GCN4 and (2.90.8) &#215; 10<sup>-8</sup> M for rGCN4) (Hollenbeck <i class="italic">et al.</i>, 2001). The
+
         GCN4 and (2.90.8) × 10<sup>-8</sup> M for rGCN4) (Hollenbeck <i class="italic">et al.</i>, 2001). The
 
         differences could be due to the lower sensitivity of SYBR-Safe staining compared to radio-labeled oligos.
 
         differences could be due to the lower sensitivity of SYBR-Safe staining compared to radio-labeled oligos.
         Most likely, the protein concentration was miscalculated due to the presence of additional (lower intensity) bands in
+
         Most likely, the protein concentration was miscalculated due to the presence of additional (lower intensity)
 +
        bands in
 
         the SDS-PAGE analysis, indicating the co-purification of small amounts of unspecific proteins.
 
         the SDS-PAGE analysis, indicating the co-purification of small amounts of unspecific proteins.
         <br><br>
+
         <br /><br />
 
         The FLAG-tag fusion to the N-terminus of proteins could potentially decrease binding affinity, likely due
 
         The FLAG-tag fusion to the N-terminus of proteins could potentially decrease binding affinity, likely due
 
         to steric hindrance affecting the interaction with DNA. Interestingly, the differences in binding affinity
 
         to steric hindrance affecting the interaction with DNA. Interestingly, the differences in binding affinity
Line 414: Line 461:
 
         FLAG-tag can be cleaved using an enterokinase and potential changes in binding affinity analyzed
 
         FLAG-tag can be cleaved using an enterokinase and potential changes in binding affinity analyzed
 
       </p>
 
       </p>
 +
    </div>
 
   </section>
 
   </section>
   <section id="5">
+
   <section>
     <h1>5. References</h1>
+
     <h2>4.3 <i>In Silico</i> Characterization using DaVinci</h2>
     <p>Fried, M. G. (1989). Measurement of protein-DNA interaction parameters by electrophoresis mobility shift assay. <em>ELECTROPHORESIS, 10</em>(5–6), 366–376. <a href="https://doi.org/10.1002/elps.1150100515" target="_blank">https://doi.org/10.1002/elps.1150100515</a></p>
+
     <p>
 
+
      We developed the in silico model <a href="https://2024.igem.wiki/heidelberg/model" target="_blank">DaVinci</a>
    <p>Hellman, L. M., & Fried, M. G. (2007). Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions. <em>Nature Protocols, 2</em>(8), 1849–1861. <a href="https://doi.org/10.1038/nprot.2007.249" target="_blank">https://doi.org/10.1038/nprot.2007.249</a></p>
+
      for rapid engineering
     <p>Hollenbeck, J. J., Gurnon, D. G., Fazio, G. C., Carlson, J. J., & Oakley, M. G. (2001). A GCN4 Variant with a C-Terminal Basic Region Binds to DNA with Wild-Type Affinity. <em>Biochemistry, 40</em>(46), 13833–13839.</p>
+
      and development of our PiCasSO system.
 
+
      DaVinci acts as a digital twin to PiCasSO, designed to understand the forces acting on our system,
     <p>Hollenbeck, J. J., & Oakley, M. G. (2000). GCN4 Binds with High Affinity to DNA Sequences Containing a Single Consensus Half-Site. <em>Biochemistry, 39</em>(21), 6380–6389. <a href="https://doi.org/10.1021/bi992705n" target="_blank">https://doi.org/10.1021/bi992705n</a></p>
+
      refine experimental parameters, and find optimal connections between protein staples and target DNA.
      
+
      We calibrated DaVinci with literature and our own experimental affinity data obtained via EMSA assays and
 +
      purified
 +
      proteins. This enabled us to simulate enhancer hijacking in silico, providing valuable input for the design of
 +
      further
 +
      experiments. Additionally, we apply the same approach to our part collection.
 +
      DaVinci is divided into three phases: static structure prediction, all-atom dynamics simulation, and long-ranged
 +
      dna
 +
      dynamics simulation. We applied the first two to our parts, characterizing structure and dynamics of the
 +
      dna-binding
 +
      interaction.
 +
    </p>
 +
     <p>
 +
      In our efforts to create a bivalent DNA binding protein with minimal size, we designed a Mini staple consisting of
 +
      GCN4 fused with an GSG-linker to rGCN4. The structure and binding affinity of GCN4 were predicted and calculated.
 +
      Furthermore different possible linkers were tested, based on dimerization and DNA binding affinity.
 +
    </p>
 +
     <!--Image Leucine zipper bla blub DryLab
 +
    <div class="thumb">
 +
      <div class="thumbinner" style="width:60%;">
 +
        <img alt="" class="thumbimage"
 +
          src="" style="width:99%;" />
 +
        <div class="thumbcaption">
 +
          <i><b>Figure 5: DaVinci simulation of GCN4 and rGCN4</b> DaVinci simulation of GCN4 and rGCN4 binding to DNA.
 +
            The
 +
            simulation was used to predict the binding affinity of the two proteins and to optimize the linker between
 +
            them.</i>
 +
        </div>
 +
      </div>
 +
     </div>
 +
      -->
 
   </section>
 
   </section>
    
+
</section>
</body>
+
<section id="5">
 +
   <h1>5. References</h1>
 +
  <p>Fried, M. G. (1989). Measurement of protein-DNA interaction parameters by electrophoresis mobility shift assay.
 +
    <em>ELECTROPHORESIS, 10</em>(5–6), 366–376. <a href="https://doi.org/10.1002/elps.1150100515"
 +
      target="_blank">https://doi.org/10.1002/elps.1150100515</a>
 +
  </p>
 +
  <p>Hellman, L. M., &amp; Fried, M. G. (2007). Electrophoretic mobility shift assay (EMSA) for detecting
 +
    protein-nucleic acid interactions. <em>Nature Protocols, 2</em>(8), 1849–1861. <a
 +
      href="https://doi.org/10.1038/nprot.2007.249" target="_blank">https://doi.org/10.1038/nprot.2007.249</a></p>
 +
  <p>Hollenbeck, J. J., Gurnon, D. G., Fazio, G. C., Carlson, J. J., &amp; Oakley, M. G. (2001). A GCN4 Variant with a
 +
    C-Terminal Basic Region Binds to DNA with Wild-Type Affinity. <em>Biochemistry, 40</em>(46), 13833–13839.</p>
 +
  <p>Hollenbeck, J. J., &amp; Oakley, M. G. (2000). GCN4 Binds with High Affinity to DNA Sequences Containing a Single
 +
    Consensus Half-Site. <em>Biochemistry, 39</em>(21), 6380–6389. <a href="https://doi.org/10.1021/bi992705n"
 +
      target="_blank">https://doi.org/10.1021/bi992705n</a></p>
 +
</section>
 +
 
  
 
</html>
 
</html>

Revision as of 23:19, 30 September 2024

BBa_K5237007

Staple subunit: GCN4

GCN4 is a yeast transcription factor belonging to the bZip family of DNA-binding proteins. We use GCN4 to study DNA-binding kinetics in our "Mini staples" that bring two DNA target sites into proximity by binding them simultaneously.

 



The PICasSO Toolbox
Figure 1: How our part collection can be used to engineer new staples


Next to the well-studied linear DNA sequence, the 3D spatial organization of DNA plays a crucial role in gene regulation, cell fate, disease development and more. However, the tools to precisely manipulate this genomic architecture remain limited, rendering it challenging to explore the full potential of the 3D genome in synthetic biology. We - iGEM Team Heidelberg 2024 - have developed PICasSO, a powerful molecular toolbox based on various DNA-binding proteins to address this issue.

The PICasSO part collection offers a comprehensive, modular platform for precise manipulation and re-programming of DNA-DNA interactions using protein staples in living cells, enabling researchers to recreate natural 3D genomic interactions, such as enhancer hijacking, or to design entirely new spatial architectures for gene regulation. Beyond its versatility, PICasSO includes robust assay systems to support the engineering, optimization, and testing of new staples, ensuring functionality in vitro and in vivo. We took special care to include parts crucial for testing every step of the cycle (design, build, test, learn) when engineering new parts.

At its heart, the PICasSO part collection consists of three categories.
(i) Our DNA-binding proteins include our finalized enhancer hijacking Cas staple as well as half staples that can be used by scientists to compose entirely new Cas staples in the future. We also include our Simple staples that serve as controls for successful stapling and can be further engineered to create alternative, simpler and more compact staples.
(ii) As functional elements, we list additional parts that enhance the functionality of our Cas and Basic staples. These consist of protease-cleavable peptide linkers and inteins that allow condition-specific, dynamic stapling in vivo. Besides staple functionality, we also include the parts to enable the efficient delivery of PICasSO's constructs with our interkingdom conjugation system.
(iii) As the final category of our collection, we provide parts that support the use of our custom readout systems. These include components of our established FRET-based proximity assay system, enabling users to confirm accurate stapling. Additionally, we offer a complementary, application-oriented testing system for functional readouts via a luciferase reporter, which allows for straightforward experimental simulation of enhancer hijacking in mammalian cells.

The following table gives a comprehensive overview of all parts in our PICasSO toolbox. The highlighted parts showed exceptional performance as described on our iGEM wiki and can serve as a reference. The other parts in the collection are versatile building blocks designed to provide future iGEMers with the flexibility to engineer their own custom Cas staples, enabling further optimization and innovation.

Our part collection includes:

DNA-binding proteins: The building blocks for engineering of custom staples for DNA-DNA interactions with a modular system ensuring easy assembly.
BBa_K5237000 fgRNA Entry vector MbCas12a-SpCas9 Entryvector for simple fgRNA cloning via SapI
BBa_K5237001 Staple subunit: dMbCas12a-Nucleoplasmin NLS Staple subunit that can be combined with sgRNA or fgRNA and dCas9 to form a functional staple
BBa_K5237002 Staple subunit: SV40 NLS-dSpCas9-SV40 NLS Staple subunit that can be combined witha sgRNA or fgRNA and dCas12avto form a functional staple
BBa_K5237003 Cas Staple: SV40 NLS-dMbCas12a-dSpCas9-Nucleoplasmin NLS Functional Cas staple that can be combined with sgRNA or fgRNA to bring two DNA strands into close proximity
BBa_K5237004 Staple subunit: Oct1-DBD Staple subunit that can be combined to form a functional staple, for example with TetR.
Can also be combined with a fluorescent protein as part of the FRET proximity assay
BBa_K5237005 Staple subunit: TetR Staple subunit that can be combined to form a functional staple, for example with Oct1.
Can also be combined with a fluorescent protein as part of the FRET proximity assay
BBa_K5237006 Simple staple: TetR-Oct1 Functional staple that can be used to bring two DNA strands in close proximity
BBa_K5237007 Staple subunit: GCN4 Staple subunit that can be combined to form a functional staple, for example with rGCN4
BBa_K5237008 Staple subunit: rGCN4 Staple subunit that can be combined to form a functional staple, for example with rGCN4
BBa_K5237009 Mini staple: bGCN4 Assembled staple with minimal size that can be further engineered
Functional elements: Protease-cleavable peptide linkers and inteins are used to control and modify staples for further optimization for custom applications
BBa_K5237010 Cathepsin B-cleavable Linker: GFLG Cathepsin B-cleavable peptide linker that can be used to combine two staple subunits to make responsive staples
BBa_K5237011 Cathepsin B Expression Cassette Expression Cassette for the overexpression of cathepsin B
BBa_K5237012 Caged NpuN Intein A caged NpuN split intein fragment that undergoes protein trans-splicing after protease activation. Can be used to create functionalized staples units
BBa_K5237013 Caged NpuC Intein A caged NpuC split intein fragment that undergoes protein trans-splicing after protease activation. Can be used to create functionalized staples units
BBa_K5237014 fgRNA processing casette Processing casette to produce multiple fgRNAs from one transcript, that can be used for multiplexed 3D genome reprograming
BBa_K5237015 Intimin anti-EGFR Nanobody Interkindom conjugation between bacteria and mammalian cells, as alternative delivery tool for large constructs
BBa_K4643003 incP origin of transfer Origin of transfer that can be cloned into the plasmid vector and used for conjugation as a means of delivery
Readout Systems: FRET and enhancer recruitment to measure proximity of stapled DNA in bacterial and mammalian living cells enabling swift testing and easy development for new systems
BBa_K5237016 FRET-Donor: mNeonGreen-Oct1 FRET Donor-Fluorpohore fused to Oct1-DBD that binds to the Oct1 binding cassette. Can be used to visualize DNA-DNA proximity
BBa_K5237017 FRET-Acceptor: TetR-mScarlet-I Acceptor part for the FRET assay binding the TetR binding cassette. Can be used to visualize DNA-DNA proximity
BBa_K5237018 Oct1 Binding Casette DNA sequence containing 12 Oct1 binding motifs, compatible with various assays such as the FRET proximity assay
BBa_K5237019 TetR Binding Cassette DNA sequence containing 12 Oct1 binding motifs, can be used for different assays such as the FRET proximity assay
BBa_K5237020 Cathepsin B-Cleavable Trans-Activator: NLS-Gal4-GFLG-VP64 Readout system that responds to protease activity. It was used to test cathepsin B-cleavable linker
BBa_K5237021 NLS-Gal4-VP64 Trans-activating enhancer, that can be used to simulate enhancer hijacking
BBa_K5237022 mCherry Expression Cassette: UAS, minimal Promotor, mCherry Readout system for enhancer binding. It was used to test cathepsin B-cleavable linker
BBa_K5237023 Oct1 - 5x UAS binding casette Oct1 and UAS binding cassette, that was used for the simulated enhancer hijacking assay
BBa_K5237024 TRE-minimal promoter- firefly luciferase Contains Firefly luciferase controlled by a minimal promoter. It was used as a luminescence readout for simulated enhancer hijacking

1. Sequence overview

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

2. Usage and Biology

GCN4 is a yeast transcription factor from the bZip family of DNA-binding proteins, first discovered by McKnight and co-workers in 1988. The bZip motif features a coiled-coil leucine zipper dimerization domain paired with a highly charged basic region, which directly interacts with DNA. GCN4 binds specifically to the cyclic AMP response element (CRE) DNA sequence (5' ATGACGTCAT 3') in the promoter regions of target genes, primarily through its basic residues at the N-terminus.

In our project, GCN4 was employed to study DNA-binding kinetics and develop a minimal "Mini staple" that brings two DNA target sites into proximity by binding them simultaneously. This "Mini staple" was designed as a versatile tool for precise DNA manipulation in synthetic biology applications.

The DNA-binding properties of GCN4 were tested using an electrophoretic mobility shift assay (EMSA) to quantify binding affinity and kinetics. EMSA is a widely adopted method to study DNA-protein interactions. It works on the principle that nucleic acids bound to proteins exhibit reduced electrophoretic mobility compared to unbound nucleic acids (Hellman & Fried, 2007). EMSA can be employed both qualitatively, to assess DNA-binding capabilities, and quantitatively, to determine critical parameters such as binding stoichiometry and the apparent dissociation constant (Kd) (Fried, 1989).

3. Assembly and part evolution

The GCN4 amino acid sequence was taken from literature (Hollenbeck et al. 2001) and codon optimized for E. coli. A FLAG-tag (DYKDDDDK) was added to the N-terminus for protein purification. The FLAG-tag can be cleaved off using an Enterokinase, if necessary. The FLAG-GCN4 sequence was cloned into a T7 expression vector and expressed using E. coli BL21 (DE3) cells.

4. Results

4.1 Protein expression and purification

The FLAG-GCN4 protein could be readily expressed in E. coli BL21 (DE3). The protein was purified using an anti-FLAG resin. Fractions taken during purification were analyzed by SDS-PAGE. Purified protein was quantified using a Lowry assay, 1.18 mg/mL were obtained, resulting in 153 µM of monomeric FLAG-GCN4.

Figure 2: SDS-PAGE analysis of FLAG-GCN4 purification Fractions analysed are the raw lysate, flow through and eluate. Depicted is GCN4 (this part), rGCN4 (BBa_K5237008), and bGCN4 (BBa_K5237009). Protein size is indicated next to construct name and purified band with protein of interest highlighted by a red box.

4.2 Electrophoretic Mobility shift assay

Figure 3: Overview Image of Electrophoretic Mobility Shift Assay (EMSA)

The Electrophoretic mobility shift assay (EMSA) is a widely adopted method used to study DNA-protein interactions. EMSA functions on the basis that nucleic acids bound to proteins have reduced electrophoretic mobility, compared to their counterpart. (Hellman & Fried, 2007). Mobility-shift assays can both be used to qualitatively assess DNA binding capabilities or quantitatively to determine binding stoichiometry and kinetics such as the apparent dissociation constant (Kd) (Fried, 1989).

GCN4 was tested for its DNA-binding capabilities using an electrophoretic mobility shift assay (EMSA). The protein was incubated with a DNA probe containing the GCN4 binding site. The formation of a protein-DNA complex was analyzed by native PAGE. To further analyze DNA binding, quantitative shift assays were performed for GCN4 and rGCN4 (BBa_K5237008). 0.5 µM DNA were incubated with varying concentrations of protein until equilibration. After electrophoresis, bands were stained with SYBR-Safe and quantified based on pixel intensity. The obtained values were fitted to equation 1, describing formation of a 2:1 protein-DNA complex:

Θapp = Θmin + (Θmax - Θmin) × (Ka2 [L]tot2) / (1 + Ka2 [L]tot2) Equation 1

Here [L]tot describes the total protein monomer concentration, Ka corresponds to the apparent monomeric equilibration constant. The Θmin/max values are the experimentally determined site saturation values (For this experiment 0 and 1 were chosen for min and max respectively). GCN4 binds to its optimal DNA binding motif with an apparent dissociation constant Kk of (0.2930.033)×10-6 M, which is almost identical to the rGCN4 binding affinity to INVii a d of (0.2980.030)×10-6 M.

Figure 4: Quantitative EMSAQuantitative assessment of binding affinity for GCN4 and rGCN4. Proteins of different concentrations were incubated with 0.5 µM DNA until equilibrium and fraction bound analyzed, after gel electrophoresis, by dividing pixel intensity of bound fraction with pixel intensity of bound and unbound fraction. At least three separate measurements were conducted for each data point. Values are presented as mean +/- SD.

The apparent binding kinetics calculated for GCN4 ((0.2930.033) × 10-6 M) and rGCN4 ((0.2980.030) × 10-6 M) are approximately a factor 10 higher then those described in literature ((96) × 10-8 M for GCN4 and (2.90.8) × 10-8 M for rGCN4) (Hollenbeck et al., 2001). The differences could be due to the lower sensitivity of SYBR-Safe staining compared to radio-labeled oligos. Most likely, the protein concentration was miscalculated due to the presence of additional (lower intensity) bands in the SDS-PAGE analysis, indicating the co-purification of small amounts of unspecific proteins.

The FLAG-tag fusion to the N-terminus of proteins could potentially decrease binding affinity, likely due to steric hindrance affecting the interaction with DNA. Interestingly, the differences in binding affinity between GCN4 and rGCN4 appear negligible. Since GCN4 binds to DNA via its N-terminus and rGCN4 binds C-terminally, the FLAG-tag likely does not directly influence DNA binding. However, it may influence the dimerization of the proteins, which is necessary for DNA binding. To further investigate this, the FLAG-tag can be cleaved using an enterokinase and potential changes in binding affinity analyzed

4.3 In Silico Characterization using DaVinci

We developed the in silico model DaVinci for rapid engineering and development of our PiCasSO system. DaVinci acts as a digital twin to PiCasSO, designed to understand the forces acting on our system, refine experimental parameters, and find optimal connections between protein staples and target DNA. We calibrated DaVinci with literature and our own experimental affinity data obtained via EMSA assays and purified proteins. This enabled us to simulate enhancer hijacking in silico, providing valuable input for the design of further experiments. Additionally, we apply the same approach to our part collection. DaVinci is divided into three phases: static structure prediction, all-atom dynamics simulation, and long-ranged dna dynamics simulation. We applied the first two to our parts, characterizing structure and dynamics of the dna-binding interaction.

In our efforts to create a bivalent DNA binding protein with minimal size, we designed a Mini staple consisting of GCN4 fused with an GSG-linker to rGCN4. The structure and binding affinity of GCN4 were predicted and calculated. Furthermore different possible linkers were tested, based on dimerization and DNA binding affinity.

5. References

Fried, M. G. (1989). Measurement of protein-DNA interaction parameters by electrophoresis mobility shift assay. ELECTROPHORESIS, 10(5–6), 366–376. https://doi.org/10.1002/elps.1150100515

Hellman, L. M., & Fried, M. G. (2007). Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions. Nature Protocols, 2(8), 1849–1861. https://doi.org/10.1038/nprot.2007.249

Hollenbeck, J. J., Gurnon, D. G., Fazio, G. C., Carlson, J. J., & Oakley, M. G. (2001). A GCN4 Variant with a C-Terminal Basic Region Binds to DNA with Wild-Type Affinity. Biochemistry, 40(46), 13833–13839.

Hollenbeck, J. J., & Oakley, M. G. (2000). GCN4 Binds with High Affinity to DNA Sequences Containing a Single Consensus Half-Site. Biochemistry, 39(21), 6380–6389. https://doi.org/10.1021/bi992705n